Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $1.36 in the prior trading day, Opko Health Inc (NASDAQ: OPK) closed at $1.28, down -5.88%. In other words, the price has decreased by -$5.88 from its previous closing price. On the day, 9.84 million shares were traded.
Ratios:
Our goal is to gain a better understanding of OPK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.28.
On June 29, 2023, Barrington Research Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $2.
On December 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $3.H.C. Wainwright initiated its Buy rating on December 15, 2022, with a $3 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 10 ’25 when FROST PHILLIP MD ET AL bought 125,000 shares for $1.36 per share. The transaction valued at 169,712 led to the insider holds 214,001,448 shares of the business.
FROST PHILLIP MD ET AL bought 125,000 shares of OPK for $184,650 on Apr 08 ’25. The CEO & Chairman now owns 213,876,448 shares after completing the transaction at $1.48 per share. On Apr 01 ’25, another insider, FROST PHILLIP MD ET AL, who serves as the CEO & Chairman of the company, bought 100,000 shares for $1.65 each. As a result, the insider paid 164,850 and bolstered with 213,751,448 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47 while its Price-to-Book (P/B) ratio in mrq is 0.66.
Stock Price History:
Over the past 52 weeks, OPK has reached a high of $2.04, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is -20.60%, while the 200-Day Moving Average is calculated to be -17.51%.
Shares Statistics:
A total of 671.61M shares are outstanding, with a floating share count of 358.23M. Insiders hold about 54.83% of the company’s shares, while institutions hold 27.08% stake in the company.
Earnings Estimates
The current assessment of Opko Health Inc (OPK) involves the perspectives of 1 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.37 and -$0.37 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is -$0.34, with 1.0 analysts recommending between -$0.34 and -$0.34.
Revenue Estimates
6 analysts predict $165.7M in revenue for the current quarter. It ranges from a high estimate of $166.7M to a low estimate of $163.5M. As of the current estimate, Opko Health Inc’s year-ago sales were $182.2MFor the next quarter, 6 analysts are estimating revenue of $166.81M. There is a high estimate of $176.9M for the next quarter, whereas the lowest estimate is $147M.
A total of 7 analysts have provided revenue estimates for OPK’s current fiscal year. The highest revenue estimate was $680.7M, while the lowest revenue estimate was $616.35M, resulting in an average revenue estimate of $652.28M. In the same quarter a year ago, actual revenue was $713.1MBased on 7 analysts’ estimates, the company’s revenue will be $703.12M in the next fiscal year. The high estimate is $769.4M and the low estimate is $614M.
